Stefan Habringer
8PUBLICATIONS
59CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Dec 18, 2025
The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.Kaiting Jiang, Marieluise Kirchner, Frederik Herzberg
|Nov 26, 2025
The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.Kaiting Jiang, Marieluise Kirchner, Frederik Herzberg
|Jun 17, 2024
A diagnostic challenge of KIT p.V559D and BRAF p.G469A mutations in a paragastric mass.Stefan Habringer, Jana Ihlow, Karsten Kleo
|May 11, 2024
Plasmapheresis effectively abrogates severe liver toxicity of pegaspargase in a patient with acute lymphoblastic leukemia.Markus Tölle, Nicola Gökbuget, Stefan Habringer
|Aug 18, 2023
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency.Jonas S Heitmann, Claudia Tandler, Maddalena Marconato
|Feb 24, 2022
NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer.Josefina Doffo, Stefanos A Bamopoulos, Hazal Köse
Pageof 2
Frequent Collaborators
7 joint publications
Ulrich Keller
5 joint publications
Matthias Wirth
2 joint publications
Richard Lewis
2 joint publications
Marieluise Kirchner
2 joint publications
Katja Steiger
2 joint publications
Jan Krönke
2 joint publications
Yan Zhao
2 joint publications
Apoorva Baluapuri
2 joint publications
Frederik Herzberg
2 joint publications
Kaiting Jiang
